New Haven, CT5 Active Studies

Ulcerative Colitis Clinical Trials in New Haven, CT

Find 5 actively recruiting ulcerative colitis clinical trials in New Haven, CT. Connect with local research sites and explore new treatment options.

5
Active Trials
5
Sponsors
1,492
Enrolling

Recruiting Ulcerative Colitis Studies in New Haven

RecruitingNew Haven, CTNCT05079841

The Stimulation To Induce Mothers Study

The investigators propose a parallel group randomized clinical trial of intrapartum nipple stimulation versus exogenous oxytocin infusion for nulliparous women undergoing induction of labor near term....

988 participants
Yale University
View Study Details
RecruitingNew Haven, CTNCT05181137

A Phase 3 Study to Investigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerative Colitis

This is a randomized, double-blind, placebo-controlled, multicenter Phase 3 study that will enroll approximately 368 subjects aged 18 to 75 years old with Moderately to Severely Active Ulcerative Coli...

368 participants
Reistone Biopharma Company Limited
View Study Details
RecruitingNew Haven, CTNCT05785819

A Phase 2 Study of VLX-1005 Versus Placebo in Suspected Heparin Induced Thrombocytopenia

The purpose of this study is to evaluate the efficacy and safety of VLX-1005, a 12-lipoxygenase (12-LOX) enzyme inhibitor in treating heparin induced thrombocytopenia (HIT). Participants with suspecte...

60 participants
Veralox Therapeutics
View Study Details
RecruitingNew Haven, CTNCT06636656

A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis

Adults between 18 and 80 years of age with ulcerative colitis can participate in this study. This is a study for people for whom previous treatment was not successful or who stopped previous treatment...

40 participants
Boehringer Ingelheim
View Study Details
RecruitingNew Haven, CTNCT06315738

Study to Assess the Safety, Tolerability, and Preliminary Efficacy of ST266 in Infants With Necrotizing Enterocolitis

The primary objective of this study is to determine the safety and tolerability of two dose levels (0.5 mL/kg and 1.0 mL/kg) of once daily (QD) via IV route of administration of ST266 in treating pati...

36 participants
Noveome Biotherapeutics, formerly Stemnion
View Study Details

About Ulcerative Colitis Clinical Trials in New Haven

Ulcerative colitis is a chronic inflammatory bowel disease that causes inflammation and ulcers in the innermost lining of the colon and rectum. It typically presents with bloody diarrhea, abdominal pain, and urgency. Treatment includes aminosalicylates, corticosteroids, immunosuppressants, and biologics.

There are currently 5 ulcerative colitis clinical trials recruiting participants in New Haven, CT. These studies are seeking a combined 1,492 participants. Research is being sponsored by Yale University, Reistone Biopharma Company Limited, Veralox Therapeutics and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ulcerative Colitis Clinical Trials in New Haven — FAQ

Are there ulcerative colitis clinical trials in New Haven?

Yes, there are 5 ulcerative colitis clinical trials currently recruiting in New Haven, CT. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New Haven?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Haven research site will contact you about next steps.

Are clinical trials in New Haven free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Haven studies also compensate for your time and travel.

What ulcerative colitis treatments are being tested?

The 5 active trials in New Haven are testing new therapies including novel drugs, biologics, and treatment approaches for ulcerative colitis.

Data updated March 2, 2026 from ClinicalTrials.gov